Literature DB >> 17630284

Reticular nucleus-specific changes in alpha3 subunit protein at GABA synapses in genetically epilepsy-prone rats.

Xiao-Bo Liu1, Jeffrey Coble, Gilles van Luijtelaar, Edward G Jones.   

Abstract

Differential composition of GABA(A) receptor (GABA(A)R) subunits underlies the variability of fast inhibitory synaptic transmission; alteration of specific GABA(A)R subunits in localized brain regions may contribute to abnormal brain states such as absence epilepsy. We combined immunocytochemistry and high-resolution ImmunoGold electron microscopy to study cellular and subcellular localization of GABA(A)R alpha1, alpha3, and beta2/beta3 subunits in ventral posterior nucleus (VP) and reticular nucleus (RTN) of control rats and WAG/Rij rats, a genetic model of absence epilepsy. In control rats, alpha1 subunits were prominent at inhibitory synapses in VP and much less prominent in RTN; in contrast, the alpha3 subunit was highly evident at inhibitory synapses in RTN. beta2/beta3 subunits were evenly distributed at inhibitory synapses in both VP and RTN. ImmunoGold particles representing all subunits were concentrated at postsynaptic densities with no extrasynaptic localization. Calculated mean number of particles for alpha1 subunit per postsynaptic density in nonepileptic VP was 6.1 +/- 3.7, for alpha3 subunit in RTN it was 6.6 +/- 3.4, and for beta2/beta3 subunits in VP and RTN the mean numbers were 3.7 +/- 1.3 and 3.5 +/- 1.2, respectively. In WAG/Rij rats, there was a specific loss of alpha3 subunit immunoreactivity at inhibitory synapses in RTN, without reduction in alpha3 subunit mRNA or significant change in immunostaining for other markers of RTN cell identity such as GABA or parvalbumin. alpha3 immunostaining in cortex was unchanged. Subtle, localized changes in GABA(A)R expression acting at highly specific points in the interconnected thalamocortical network lie at the heart of idiopathic generalized epilepsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630284      PMCID: PMC1916487          DOI: 10.1073/pnas.0705320104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Nucleus-specific differences in GABA(A)-receptor-mediated inhibition are enhanced during thalamic development.

Authors:  M M Huntsman; J R Huguenard
Journal:  J Neurophysiol       Date:  2000-01       Impact factor: 2.714

Review 2.  Childhood absence epilepsy: genes, channels, neurons and networks.

Authors:  Vincenzo Crunelli; Nathalie Leresche
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

3.  Activity of thalamic reticular neurons during spontaneous genetically determined spike and wave discharges.

Authors:  Sean J Slaght; Nathalie Leresche; Jean-Michel Deniau; Vincenzo Crunelli; Stephane Charpier
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

4.  Nucleus-specific abnormalities of GABAergic synaptic transmission in a genetic model of absence seizures.

Authors:  Thomas Bessaïh; Laurence Bourgeais; Carmen I Badiu; David A Carter; Tibor I Toth; Diego Ruano; Bertrand Lambolez; Vincenzo Crunelli; Nathalie Leresche
Journal:  J Neurophysiol       Date:  2006-09-13       Impact factor: 2.714

5.  Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.

Authors:  R H Wallace; C Marini; S Petrou; L A Harkin; D N Bowser; R G Panchal; D A Williams; G R Sutherland; J C Mulley; I E Scheffer; S F Berkovic
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

6.  Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.

Authors:  David N Bowser; David A Wagner; Cynthia Czajkowski; Brett A Cromer; Michael W Parker; Robyn H Wallace; Louise A Harkin; John C Mulley; Carla Marini; Samuel F Berkovic; David A Williams; Mathew V Jones; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

7.  Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus.

Authors:  Louise A Harkin; David N Bowser; Leanne M Dibbens; Rita Singh; Fiona Phillips; Robyn H Wallace; Michaella C Richards; David A Williams; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer; Steven Petrou
Journal:  Am J Hum Genet       Date:  2001-12-17       Impact factor: 11.025

8.  Mutation screen of the GABA(A) receptor gamma 2 subunit gene in Chinese patients with childhood absence epilepsy.

Authors:  Jianjun Lu; Yucai Chen; Yuehua Zhang; Hong Pan; Husheng Wu; Keming Xu; Xiaoyan Liu; Yuwu Jiang; Xinhua Bao; Keyue Ding; Yan Shen; Xiru Wu
Journal:  Neurosci Lett       Date:  2002-10-31       Impact factor: 3.046

9.  Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats.

Authors:  Hanneke K M Meeren; Jan Pieter M Pijn; Egidius L J M Van Luijtelaar; Anton M L Coenen; Fernando H Lopes da Silva
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

10.  Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans.

Authors:  Matt T Bianchi; Luyan Song; Helen Zhang; Robert L Macdonald
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  14 in total

1.  MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood.

Authors:  Leigh A Needleman; Xiao-Bo Liu; Faten El-Sabeawy; Edward G Jones; A Kimberley McAllister
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

2.  Normal sleep homeostasis and lack of epilepsy phenotype in GABA A receptor alpha3 subunit-knockout mice.

Authors:  R Winsky-Sommerer; A Knapman; D E Fedele; C M Schofield; V V Vyazovskiy; U Rudolph; J R Huguenard; J-M Fritschy; I Tobler
Journal:  Neuroscience       Date:  2008-04-11       Impact factor: 3.590

3.  Comparative proteomic approach in rat model of absence epilepsy.

Authors:  Gönül Gürol; Duygu Özel Demiralp; Ayça Kasapoğlu Yılmaz; Özlem Akman; Nurbay Ateş; Ayşe Karson
Journal:  J Mol Neurosci       Date:  2014-10-17       Impact factor: 3.444

4.  GABAA receptors in GtoPdb v.2021.3.

Authors:  Delia Belelli; Tim G Hales; Jeremy J Lambert; Bernhard Luscher; Richard Olsen; John A Peters; Uwe Rudolph; Werner Sieghart
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

5.  Diminished presynaptic GABA(B) receptor function in the neocortex of a genetic model of absence epilepsy.

Authors:  Yugi Inaba; Margherita D'Antuono; Giuliano Bertazzoni; Giuseppe Biagini; Massimo Avoli
Journal:  Neurosignals       Date:  2009-01-29

6.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

7.  Anti-epileptogenesis: Electrophysiology, diffusion tensor imaging and behavior in a genetic absence model.

Authors:  Gilles van Luijtelaar; Asht M Mishra; Peter Edelbroek; Daniel Coman; Nikita Frankenmolen; Pauline Schaapsmeerders; Giulio Covolato; Nathan Danielson; Hannah Niermann; Kryzstof Janeczko; Anne Kiemeneij; Julija Burinov; Chhitij Bashyal; Madeline Coquillette; Annika Lüttjohann; Fahmeed Hyder; Hal Blumenfeld; Clementina M van Rijn
Journal:  Neurobiol Dis       Date:  2013-08-23       Impact factor: 5.996

Review 8.  Transition to absence seizures and the role of GABA(A) receptors.

Authors:  Vincenzo Crunelli; David W Cope; John R Terry
Journal:  Epilepsy Res       Date:  2011-09-01       Impact factor: 3.045

9.  Novel β-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability.

Authors:  Marta B Wisniewska; Andrzej Nagalski; Michal Dabrowski; Katarzyna Misztal; Jacek Kuznicki
Journal:  BMC Genomics       Date:  2012-11-17       Impact factor: 3.969

10.  Epilepsy, E/I Balance and GABA(A) Receptor Plasticity.

Authors:  Jean-Marc Fritschy
Journal:  Front Mol Neurosci       Date:  2008-03-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.